Correlation Engine 2.0
Clear Search sequence regions

  • blood clot (1)
  • diagnosis (1)
  • hemostasis (4)
  • humans (1)
  • plasma (1)
  • platelets (2)
  • prognosis (1)
  • research (1)
  • stroke (1)
  • thrombosis (5)
  • Sizes of these terms reflect their relevance to your search.

    Proteomics, the simultaneous study of all proteins in a given cell, tissue or organism, is an innovative approach used to identify novel markers for diagnosis, prognosis and the pathophysiological mechanisms associated with diseases. Proteomic methodologies have been used in a variety of contexts such as investigating changes in protein abundance that may occur with disease presence, the response to therapeutic treatments as well as the impacts of age on the plasma proteome.Over the last decade, significant technological advancements in proteomic techniques have resulted in an increase in the use of proteomics in thrombosis and hemostasis research, particularly in order to identify relevant and novel clinical markers associated with bleeding and thrombosis. This mini-review explores the use of proteomics in the setting of thrombosis and hemostasis from 2010-2020, across five main domains (platelets, blood clot composition, stroke, venous thromboembolism, and therapeutics), as well as provides insights into key considerations for conducting proteomic studies. Thieme. All rights reserved.


    Natasha Letunica, Suelyn Van Den Helm, Conor McCafferty, Ella Swaney, Tengyi Cai, Chantal Attard, Vasiliki Karlaftis, Paul Monagle, Vera Ignjatovic. Proteomics in Thrombosis and Hemostasis. Thrombosis and haemostasis. 2022 Jul;122(7):1076-1084

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 34753192

    View Full Text